V2L (p.Val2Leu) variant of HTR2C (5-hydroxytryptamine receptor 2C)

V2L (p.Val2Leu) in HTR2C (5-hydroxytryptamine receptor 2C) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data and structural context.

V2L (p.Val2Leu) variant details